A Research Study Looking at Different Oral Formulations and the Effect of Food Intake on How the Medicine NNC0487-0111 Behaves in the Body of Participants Living With Overweight or Obesity

NCT06478563 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

133

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity
Overweight

Interventions

DRUG: NNC0487-0111 (formulation D)
DRUG: NNC0487-0111 (formulation C)

Sponsor

Novo Nordisk A/S